"Virginia Oncology Associates is an oncology and hematology practice of physicians, specializing in the diagnosis and treatment of cancer and blood disorders. With locations spanning the southeast region of Virginia and Northeastern North Carolina, we are able to extend services and treatments to patients, including medical oncology, radiation oncology, gynecologic oncology, hematology, diagnostics, clinical research, stem cell transplantation, genetic counseling, and psychosocial oncology."

During the past decade, Virginia Oncology Associates - Lake Wright conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Oncology Associates - Lake Wright" #1 sponsor was "National Cancer Institute (NCI)" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Oncology Associates - Lake Wright" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Oncology Associates - Lake Wright" are "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials), "Fallopian Tube Mucinous Adenocarcinoma" (3 trials), "Fallopian Tube Transitional Cell Carcinoma" (3 trials), "Ovarian Brenner Tumor" (3 trials) and "Ovarian Endometrioid Adenocarcinoma" (3 trials). Many other conditions were trialed in "Virginia Oncology Associates - Lake Wright" in a lesser frequency.

Most popular intervention types in "Virginia Oncology Associates - Lake Wright" are "Drug" (20 trials), "Other" (9 trials), "Biological" (5 trials), "Procedure" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Atezolizumab" (4 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Oncology Associates - Lake Wright" are 14 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Oncology Associates - Lake Wright". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Virginia Oncology Associates - Lake Wright, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Oncology Associates - Lake Wright, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".